FIELD: chemical-pharmaceutical industry. SUBSTANCE: method involves lyophilization of photophryn II frozen solution without sodium chloride at temperature from 35 to 20-25 C, exposition for 5 h, increase of temperature up to 33-37 C and exposition for 6-18 h. The end product shows increased stability. EFFECT: enhanced quality of the end product. 6 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| AGENT FOR PHOTODYNAMIC DIAGNOSIS AND THERAPY OF ONCOLOGICAL DISEASES | 1999 |
|
RU2152790C1 |
| METHOD OF MAMMALIAN TUMOR CELL DESTRUCTION AND PHARMACEUTICAL COMPOSITION FOR MAMMALIAN TUMOR CELLS DESTRUCTION | 1989 |
|
RU2074719C1 |
| BIS(THIO-HYDRAZIDE AMIDE) COMPOSITION | 2006 |
|
RU2433822C2 |
| PHOTODYNAMIC THERAPY FOR SELECTIVE BLOOD CELLS INACTIVATION AND TREATMENT OF DISEASES WITH IMMUNE DISFUNCTION | 1995 |
|
RU2166331C2 |
| METHOD OF POLYPEPTIDE SYNTHESIS | 1990 |
|
RU2037498C1 |
| LYOPHILIZED COMPOSITION CONTAINING THIOXANTENONE AS ANTITUMOR ACTIVE PRINCIPLE AND METHOD OF TREATMENT INVOLVING THIS COMPOSITION | 1996 |
|
RU2157189C2 |
| LYOPHILISED FORMULATION CONTAINING INFLUENZA VACCINE, AND METHOD FOR PREPARING IT | 2008 |
|
RU2484847C2 |
| PHOTOCHEMOTHERAPEUTIC COMPOSITIONS | 1998 |
|
RU2194532C2 |
| METHOD OF PREPARING OF POLYPEPTIDE WHICH ABLE TO BLOCK CALCIUM CHANNELS | 1990 |
|
RU2026866C1 |
| POLYPEPTIDE OR ITS PHARMACEUTICALLY ACCEPTABLE SALTS | 1993 |
|
RU2104286C1 |
